Los Angeles, CA, United States of America

Victor Reggie Edgerton

This inventor holds 31 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 7 EPO patents, primarily in Neuromodulation Technology. Top assignees: University of California, California Institute of Technology, University Of Louisville Research Foundation, Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor Reggie Edgerton. Retrieved from https://idiyas.com/inventor/victor-reggie-edgerton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 96.8

 

 

Average Co-Inventor Count = 5.1

ph-index = 12

Forward Citations = 474(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Transcutaneous Electrical Stimulation
Spinal Cord Injury
Neuromodulation Device
Epidural Stimulation
Motor Function Recovery
Neurostimulator
Microelectrode Array
Machine Learning Optimization
Non-Invasive Techniques
Autonomic Function Recovery
Posture Facilitation
Voluntary Movement
31 patents (USPTO):Explore Patents

Title: Victor Reggie Edgerton – Innovator in Neuromodulation Technologies

Introduction

Victor Reggie Edgerton, a prominent inventor based in Los Angeles, CA, is recognized for his significant contributions to the field of neuromodulation. With a remarkable portfolio of 27 patents, Edgerton's work focuses on innovative techniques designed to enhance motor, sensory, autonomic, sexual, vasomotor, and cognitive functions in mammals.

Latest Patents

Among Edgerton’s latest patents is a groundbreaking non-invasive neuromodulation device that enables the recovery of various bodily functions. This neuromodulation system includes a processor, a signal generator, a first electrode, and a second electrode, all working in harmony to provide transcutaneous stimulation to a mammal. The carefully designed connections allow the system to induce voluntary movement by placing the first electrode transcutaneously on the spinal cord and/or its dorsal roots while positioning the second electrode on or over key anatomical structures. This innovative approach signifies a substantial advancement in the field of neuromodulation.

Another significant patent from Edgerton’s collection involves a similar transcutaneous stimulation system, highlighting the versatility and effectiveness of his methodologies. Each device and method he has developed reflects his commitment to addressing complex medical conditions through advanced technology.

Career Highlights

Throughout his distinguished career, Victor Reggie Edgerton has been associated with prestigious institutions such as the University of California and the California Institute of Technology. His work at these institutions has greatly contributed to his extensive knowledge and expertise in neuromodulation, leading to the successful development of multiple patents. His innovative spirit has set a standard in the mechanistic understanding of electrical stimulation in therapeutic applications.

Collaborations

Edgerton has collaborated with notable figures in his field, including Yury P. Gerasimenko and Roland R. Roy. These partnerships have likely played a crucial role in fostering an environment of innovation and creativity, further enhancing the depth and impact of Edgerton's work in neuromodulation.

Conclusion

Victor Reggie Edgerton is a visionary inventor whose achievements in neuromodulation are paving the way for new therapeutic approaches. With his extensive portfolio of patents and collaborations with esteemed colleagues, he continues to inspire advancements in medical technology that can significantly improve patients' quality of life. As neuromodulation technologies evolve, Edgerton's contributions will certainly remain at the forefront of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…